10.1021/ja00077a082
The research focuses on the total synthesis of (-)-sandramycin, a potent antitumor antibiotic, and an investigation into its preliminary DNA binding properties. The purpose of this study was to confirm the structure and absolute stereochemistry of sandramycin and to report on its high-affinity, bifunctional intercalation with DNA. The researchers achieved the first total synthesis of a member of this class of naturally occurring agents, which could lead to the development of analogs with modified intercalation capabilities. Key chemicals used in the synthesis process included BOC-Gly-Sar-OH, D-N-Me-val-oCH2l, DCC, DMAP, EDCI, HOBt, NaHCO3, and various other reagents for coupling reactions, deprotection steps, and cyclization. The conclusions drawn from the study indicated that (-)-sandramycin possesses a binding constant comparable to luzopeptin A, binds with higher selectivity, and induces the unwinding of negatively supercoiled DNA and its rewinding at lower agent concentrations than luzopeptin A.